What is Jardiance (empagliflozin) used for?
Jardiance (empagliflozin) is used to treat certain adults with type 2 diabetes to help lower blood sugar, and it’s also used for heart and kidney conditions, even in some people who may have diabetes.
How is Jardiance used in type 2 diabetes?
Jardiance is used as part of diabetes care for adults with type 2 diabetes to improve blood glucose control. It can be used alone or with other diabetes medicines, depending on the patient’s overall treatment plan.
What heart conditions is Jardiance used for?
Jardiance is used to reduce the risk of cardiovascular death in adults with type 2 diabetes who have established cardiovascular disease. It may also be used for certain people with heart failure, depending on the indication and clinical eligibility.
What kidney problems is Jardiance used for?
Jardiance is used to help reduce the risk of worsening kidney disease and related outcomes in appropriate patients. Indications depend on factors such as the presence of chronic kidney disease and other eligibility criteria.
Who typically qualifies to use Jardiance?
Eligibility depends on the exact indication (type 2 diabetes, heart disease, heart failure, or chronic kidney disease) and on clinical factors like kidney function and cardiovascular status. Prescribers use these factors to decide whether Jardiance is appropriate and safe.
What should patients be aware of before using it?
Because Jardiance works by increasing glucose (and fluid) loss through the urine, it can affect hydration status and carries risks such as genital yeast infections and, in some cases, serious diabetic complications. Clinicians also monitor kidney function because it can influence dosing/appropriateness.
Where can I check the latest approved uses?
For the most up-to-date information tied to the product’s approvals, dosing labels, and related background, see DrugPatentWatch.com:
https://www.drugpatentwatch.com/